Octopus Apollo VCT plc : Publication of a Prospectus and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Octopus Apollo VCT plc : Publication of a Prospectus and Circulars in respect of proposals to merge with Octopus Eclipse VCT plc and an Offer for Subscription by Octopus Apollo VCT plc

Octopus Apollo VCT plc ("Apollo") Octopus Eclipse VCT plc ("Eclipse") 

(together the "Companies")

4 November 2016

Publication of a Prospectus (the "Prospectus") and Circulars (the "Circulars") in connection with recommended proposals to merge the Companies (to be completed pursuant to a scheme of reconstruction (the "Scheme" or "Merger") under section 110 Insolvency Act 1986) and an offer for subscription by Apollo.  

On 27 September 2016, the boards of Apollo and Eclipse (the "Boards") announced that they had entered into discussions to merge the Companies into one company (the "Enlarged Company") and the Apollo Board announced that it also intended to raise further funds into Apollo pursuant to an offer for subscription (the "Offer"). The Boards are pleased to advise that discussions have now concluded and that the Companies have today issued the Circulars to set out the proposals for the Merger for consideration by their respective shareholders and that Apollo has issued a Prospectus relating to the Offer and Merger. The Companies have similar investment mandates and are both managed by Octopus Investments Limited ("Octopus").

The Offer

Apollo is seeking to raise £20 million under the Offer, which is subject to the approval of the Apollo shareholders. The expected timetable for the Offer is set out below.

The Scheme

The Merger is expected to deliver a number of additional benefits to shareholders including:

  • participation in a larger VCT with a more diversified portfolio, thereby spreading the portfolio risk across a broader range of investments;
  • efficiencies in annual running costs and administration for the Enlarged Company compared to the separate companies;
  • enhancing the ability of the Enlarged Company to find high quality new investments, raise funds, as well as pay dividends and support buybacks in the future.

The mechanism by which the Merger will be completed is as follows:

  • Eclipse will be placed into members' voluntary liquidation pursuant to a scheme of reconstruction under Section 110 IA 1986; and
  • all of the assets and liabilities of Eclipse will be transferred to the Company in consideration for the issue of Scheme Shares.

The Scheme will be completed on a relative unaudited net asset value basis, adjusted for the anticipated costs of the Scheme, based on the latest unaudited valuations of the Companies' investments. An accounting firm will review the latest unaudited net asset values of the Companies and valuations of the Companies' investments prior to the Merger becoming effective and will confirm that they have been prepared in accordance with similar principles as would have been used in producing year end accounts. The effect of the Scheme will be that the Eclipse shareholders will receive Apollo shares with the same total net asset value as their Eclipse shares.

The Scheme is conditional upon its approval by the Apollo shareholders and by the Eclipse shareholders, as well as the other conditions set out in the Prospectus and Circulars.

As the Companies have a similar investment objective and policy, the same investment manager and other common advisers, the proposed Merger should be achievable without major additional cost or disruption to the Companies and their combined portfolio of investments.

The aggregate anticipated cost of undertaking the Merger is approximately £331,000, including VAT, legal and professional fees, stamp duty and the costs of winding up Eclipse. The costs of the Merger will be split proportionately between the Companies by reference to their respective net asset values immediately prior to the Merger.

Shareholders and investors should note that the merger by way of the Scheme will be outside the provisions of the City Code on Takeovers and Mergers.

The portfolio of assets which will be transferred from Eclipse to the Company as part of the Scheme is considered to be in keeping with Apollo's investment policy. The extent of the liabilities (if any) which will be transferred from Eclipse to Apollo as part of the Scheme will be those which are incurred in the ordinary course of business and merger costs which remain unpaid at the time of transfer. Any such liabilities are expected to be nominal in comparison to the value of the assets.

Eclipse shareholders who do not vote in favour of the Resolution to be proposed at Eclipse's first general meeting, as referred to in the timetable below, are entitled to dissent and have their shareholding purchased by the liquidators of Eclipse (the "Liquidators") at a price agreed between the dissenting Eclipse shareholders and the Liquidators (or by arbitration), which would be expected to be at a significant discount to the net asset value of an Eclipse share. If the conditions of the Scheme are not satisfied, the Companies will continue in their current form and the Boards will continue to review all options available to them regarding the future of the Companies.

Clearance has been requested from HMRC that the Scheme meets the requirements of the Merger Regulations and, therefore, that the implementation of the Scheme should not affect the status of Apollo as a VCT. It is the intention of the Apollo Board to continue to comply with the requirements of ITA 2007 following the Merger so that Apollo continues to qualify as a VCT.

EXPECTED TIMETABLE, OFFER STATISTICS AND COSTS

Expected Timetable for the Scheme

Apollo

Latest time and date for receipt of Forms of Proxy for the General Meeting 2.30 pm on 8 December 2016
General Meeting 2.30 pm on 12 December 2016
Scheme Calculation Date after 5.00 pm on 16 December 2016
Scheme Effective Date for the transfer of the assets and liabilities of Eclipse to the Company and the issue of Scheme Shares 19 December 2016
Announcement of the results of the Scheme 19 December 2016
Admission of, and dealings in, Scheme Shares issued to commence 20 December 2016
CREST accounts credited (if applicable) 20 December 2016 2016
Certificates for Scheme Shares despatched to Eclipse Shareholders Week commencing 9 January 2017

Eclipse

Latest time for receipt of forms of proxy for the Eclipse First General Meeting   2.30 pm on 5 December 2016
Eclipse First General Meeting   2.30 pm on 7 December 2016
Latest time for receipt of forms of proxy for the Eclipse Second General Meeting   10.30 am on 15 December 2016  
Final expected date of trading of the Eclipse Shares 16 December 2016
Scheme Record Date for Eclipse Shareholders' entitlements under the Scheme 5.00 pm on 16 December 2016
Scheme Calculation Date after 5.00 pm on 16 December 2016
Dealings in Eclipse Shares suspended* 7.30 am on 19 December 2016
Eclipse register of members closed 9.30 am on 19 December 2016
  Eclipse Second General Meeting     10.30 am on 19 December 2016  
Scheme Effective Date for the transfer of the assets and liabilities of Eclipse to the Company and the issue of Scheme Shares 19 December 2016  
Announcement of the results of the Scheme 19 December 2016  
Cancellation of the Eclipse Shares' listing 8.00 am on 20 December 2016  

(*The final expected date of trading of the Eclipse shares will be 16 December 2016. See the timetable for Apollo with regard to admission, CREST accounts being credited and certificates being despatched in respect of the Scheme Shares)

Expected Timetable for the Offer

Launch date of the Offer 4 November 2016  
Deadline for receipt of applications for first allotment 9.00 am on 5 January 2017
First allotments under the Offer 6 January 2017
Deadline for receipt of applications for final allotment in 2016/17 tax year 12 noon on 5 April 2017
Deadline for receipt of applications for final allotment in 2017/18 tax year 12 noon on 3 November 2017
Closing date of the Offer 12 noon on 3 November 2017

             

  • The Offer will close earlier if fully subscribed. The Apollo Board reserves the right to close the Offer earlier and to accept applications and issue ordinary shares under the Offer ("Offer Shares") at any time following the receipt of valid applications.  
  • The results of the Offer will be announced to the London Stock Exchange through a Regulatory Information Service provider authorised by the Financial Conduct Authority.  
  • Dealing is expected to commence in Offer Shares within ten business days of allotments and share and tax certificates are expected to be despatched within 14 business days of allotments.  
  • The dates set out in the expected timetable above may be adjusted by Apollo, in which event details of the new dates will be notified through a Regulatory Information Service.

Offer Statistics

Costs of Offer Up to 7.5% of gross proceeds of Offer
Initial adviser charge or intermediary commission Up to 4.5% of gross proceeds of Offer
Ongoing adviser charge or annual ongoing charge Up to 0.5% per annum of the latest NAV of gross sums invested in the Offer for up to 9 years
  • The cost of the Offer is capped at 7.5%. Octopus has agreed to indemnify Apollo against the costs of the Offer in excess of this amount.

Related Party Transaction

In connection with the Offer, Octopus will receive a fee of up to 5.5% of the gross proceeds received by Apollo under the Offer (comprising an initial charge of 3.0% of the gross funds raised and an initial commission of up to 2.5% of gross funds raised from investors who have not invested their money through a financial intermediary ("Direct Investors")) and an additional ongoing charge of 0.5% of the net asset value of the investment amount received by Apollo from Direct Investors, payable for up to nine years, provided the Direct Investors continue to hold their Offer shares.

The above arrangement falls within Listing Rule 11.1.10 R.

Copies of the Prospectus and Circulars will shortly be available for inspection at the National Storage Mechanism, which is located at:

http://www.morningstar.co.uk/uk/NSM

and on the Company's website:

http://www.octopusinvestments.com

For further information please contact:

Nicola Board Company Secretary 0207 776 8663

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 12

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Lavior and CR Fitness Team for Wellness Reach

Updated Category News Views 2

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 4

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 6

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 6

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 6

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
Navigating AI's New Era: Dresner's 2026 Findings

Updated Category News Views 7

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 3

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Nature-Based Solutions: The Economic And Community Impact

Updated Category News Views 8

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 3

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Walgreens Boots Alliance at Risk of Dividend Cuts

Updated Category News Views 125

Understanding Dividend Risks in Today's Market Dividend cuts and suspensions can often catch investors off guard. While it's common for investors to sense that a company's dividend might change, pinpointing the exact timing is quite tricky. However, there are warning signs that can help assess the risk to dividends. A recent example is Intel, which suspended its dividend...

Continue Reading
A Closer Look at Celsius Holdings, Inc. Legal Developments

Updated Category News Views 280

Understanding the Class Action Lawsuit Against Celsius Holdings Celsius Holdings, Inc. (NASDAQ: CELH), a recognized name in the wellness industry, is currently facing a class action lawsuit. This development is pivotal for shareholders who have incurred losses on their investments. The lawsuit brings attention to allegations of securities fraud and other unethical...

Continue Reading
ABBYY and IBM Join Forces at AI Summit in New York 2024

Updated Category News Views 116

ABBYY and IBM Unveil Innovations at AI Summit ABBYY is set to make a significant impact at the upcoming AI Summit in New York, taking place December 11-12. The company is eagerly exhibiting its state-of-the-art technologies, including its latest multimodal model, known as Phoenix. This model is designed to extract accurate data from various documents, enabling businesses...

Continue Reading
Piper Sandler Upgrades Madrigal Pharmaceuticals' Outlook

Updated Category News Views 67

Piper Sandler Maintains Strong Outlook for Madrigal Pharmaceuticals Piper Sandler has reiterated its Overweight rating along with a price target of $336.00 for Madrigal Pharmaceuticals (NASDAQ: MDGL). This positive outlook underscores the firm’s confidence in the ongoing launch of Madrigal's innovative drug, REZDIFFRA, which is poised to make a significant impact in the...

Continue Reading
IronNet and Asterion Unite to Elevate Cybersecurity Solutions

Updated Category News Views 151

IronNet and Asterion Join Forces for Enhanced Cybersecurity IronNet, an innovative player in the AI-driven collective defense cybersecurity landscape, has announced a significant partnership with Asterion, a frontrunner in counter-UAS technology. This collaboration marks an important stride toward safeguarding critical infrastructure through the integration of advanced...

Continue Reading